Brief: Vaxart Says Cash Runway Extended Into 2026
17/06/2024 23:39
June 17 (Reuters) - Vaxart Inc VXRT.O :
* VAXART PROVIDES BUSINESS UPDATE
* VAXART INC: CASH RUNWAY EXTENDED INTO 2026
* VAXART INC: RECEIVED ONE OF LARGEST BARDA-FUNDED PROJECT
NEXTGEN
AWARDS TO DATE, UP TO $453 MILLION
* VAXART INC: WELL-CAPITALIZED TO EXECUTE ON MULTIPLE KEY
CLINICAL
AND REGULATORY MILESTONES IN COVID-19 AND NOROVIRUS PROGRAMS
Source text for Eikon: ID:nGNXbwYs2t
Further company coverage: VXRT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts